Zhongchao announced that Chongqing Xinjiang Pharmaceutical Co., one of the Chinese operating entities of which the company consolidates the financial results with through certain contractual arrangements, will act as the drug distribution agent of certain drugs produced by Natco Pharma Limited within Mainland China pursuant to certain agreements. Natco is a vertically integrated and R&D focused pharmaceutical company in India. Through this cooperation, Xinjiang Pharmaceutical will introduce different products from Natco based on the needs of patients in China, for example, anti-influenza drugs during the flu season, and high demand anti-tumor and anti-rare diseases products. Both parties will work together to apply registration certificate of imported drugs and submit filings of sales agent, and will fully leverage their advantages and resources to effectively shorten the clinical trial approval and other processes and accelerate the progress of introducing quality drugs to the patients in China.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly